八旬患者二尖瓣反流:TEER与外科手术的安全、耐久性与生存比较
本研究对比≥80岁二尖瓣反流患者接受二尖瓣手术(n=390)与TEER(n=354)的结局,经倾向评分匹配后252例。
要点
- 外科组围术期并发症及住院时间更高,但残余MR和复发MR更低。
- 外科组5年生存优于TEER组(68% vs 56%),需权衡耐久性与手术风险。
核心结论
- 在≥80岁MR患者中,TEER住院更短、手术相关并发症更少,但外科手术复发MR更低且晚期生存更优。
研究设计与样本
- 2014–2024年单中心744例≥80岁接受MV手术(n=390)或TEER(n=354)的患者。
- 排除附加手术或MV狭窄后466例符合标准,1:1倾向评分匹配后最终252例。
主要发现
- 匹配后基线可比;全队列中位年龄83.5岁(IQR 81.7–85.9),78.2%为退行性MR。
- 外科组术后房颤、延长机械通气及ICU和住院时间均更高(P<.001)。
- 出院前超声示外科组残余MR更少(2.4% vs 8%;P<.001)、三尖瓣反流更少(10.5% vs 50%;P<.001)、右室收缩压更低(37.5 mmHg vs 44 mmHg;P<.001)。
- 中位随访3.9年,外科组复发MR更低(6.4% vs 33.3%;P<.001),5年生存更优(68% vs 56%;P=.019)。
临床怎么用
- 对八旬MR患者,TEER可作为降低围术期并发症和缩短住院的选择。
- 若追求更低复发MR和更好晚期生存,可优先评估外科手术耐受性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the short- and long-term outcomes of surgical and transcatheter interventions for treating mitral regurgitation (MR) in patients age ≥80 years. METHODS: Between 2014 and 2024, 744 patients age ≥80 years underwent mitral valve (MV) surgery (n = 390) or transcatheter edge-to-edge repair (TEER; n = 354) at our institution. Of these, 466 patients without additional procedures or MV stenosis met the inclusion criteria. Application of 1:1 propensity score matching yielded a final matched cohort of 252 patients. RESULTS: After matching, baseline characteristics were comparable between the TEER and MV surgery groups. In the entire study cohort, the median patient age was 83.5 years (interquartile range, 81.7-85.9 years), and 78.2% had degenerative MR. Thirty-day mortality was similar in the 2 groups (MV surgery, 1.6%; TEER, 0.8%; P = .561). Postoperatively, the MV surgery group had higher rates of atrial fibrillation, prolonged mechanical ventilation, and longer intensive care unit and hospital stays (P < .001 for all). Predischarge echocardiography showed less residual MR (2.4% vs 8%; P < .001), less tricuspid regurgitation (10.5% vs 50%, P < .001), and lower right ventricular systolic pressure (37.5 mm Hg vs 44 mm Hg; P < .001) in the MV surgery group. Over a median 3.9-year follow-up, the incidence of recurrent MR remained lower (6.4% vs 33.3%; P < .001), and 5-year survival was superior (68% vs 56%; P = .019) in the MV surgery group. CONCLUSIONS: Both surgical correction of MR and TEER can be performed relatively safely in octogenarians. Although TEER is associated with shorter hospital stays and fewer procedure-related complications, MV surgery results in a lower rate of recurrent MR and better late survival.
引用
- Danesh S, Schaff HV, Holst KA, et al. Transcatheter edge-to-edge repair versus mitral valve surgery in octogenarians: Comparative analysis of safety, durability, and survival. J Thorac Cardiovasc Surg. 2025. PMID: 40849062. doi:10.1016/j.jtcvs.2025.08.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。